Literature DB >> 33420475

Efficacy and safety of esaxerenone in patients with hypertension and concomitant heart failure.

Takashi Naruke1,2, Kenji Maemura3, Takumi Oki3, Mayu Yazaki3, Teppei Fujita3, Yuki Ikeda3, Takeru Nabeta3, Shunsuke Ishii3, Yoshiyasu Minami3, Hidehira Fukaya3, Masaru Yuge4, Takao Shimohama3, Takeo Kawaguchi4, Junya Ako3.   

Abstract

Entities:  

Keywords:  Antihypertensive drug; Mineralocorticoid receptor blocker; Plasma B-type natriuretic peptide

Mesh：

Substances：

Year:  2021        PMID： 33420475     DOI： 10.1038/s41440-020-00606-w

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  3 in total

1.  Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study.

Authors:  Togo Iwahana; Yuichi Saito; Sho Okada; Hirotoshi Kato; Ryohei Ono; Yoshio Kobayashi
Journal:  PLoS One       Date:  2021-11-08       Impact factor: 3.240

Review 2.  The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers.

Authors:  Yuta Tezuka; Sadayoshi Ito
Journal:  Curr Hypertens Rep       Date:  2022-04-30       Impact factor: 4.592

3.  Characterization of Direct Perturbations on Voltage-Gated Sodium Current by Esaxerenone, a Nonsteroidal Mineralocorticoid Receptor Blocker.

Authors:  Wei-Ting Chang; Sheng-Nan Wu
Journal:  Biomedicines       Date:  2021-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.